Kaiima Agro-biotech employs polyploidy technology, seeks $50M in equity financing

In Israel, Kaiima Agro-biotech Ltd., an agro-biotch startup, seeks to raise up to US $50M in an equity financing round to further develop their products which increase crop productivity without genetically modifying the DNA of the selected crop. Kaiima’s products take advantage of “polyploidy,” a condition which causes species to have extra sets of chromosomes. By using pliody technology, the company is able to engineering the crop’s genome without performing genetic engineering. The company’s financing round extends to wider sources and Asian investors such as Horizon Ventures and Kleiner Perkins Caufield & Byers.

More on the story.